NYSE:APUS | Balance Sheet | Apimeds Pharmaceuticals US, Inc.

Complete source-backed balance-sheet history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$278,371.00$48,501.00$10.68M$51,929.00$127.62M$21.07M$21.18M$106.45M
2026-03-31$979,534.00$1.5M$48,500.00$13.15M$56,592.00$141.22M$14.58M$14.7M$126.52M
2025-12-31$1.64M$2M$48,500.00$13.98M$51,626.00$164.18M$10.71M$10.84M$153.35M
2025-09-30$6.99M$9.09M$34,188.00$9.25M$1.09M$1.09M$8.16M
2025-06-30$8.74M$10.35M$13,137.00$10.55M$809,002.00$809,002.00$9.74M
2025-03-31$250,432.00$259,904.00$259,904.00$1.77M$2.02M-$1.76M
2024-12-31$3,455.00$13,057.00$13,057.00$1.02M$1.37M-$1.36M
2024-09-30$26,571.00-$1.05M
2024-06-30$63,326.00-$713,967.00
2024-03-31$147,381.00-$264,604.00
2023-12-31$410,481.00$422,076.00$422,076.00$123,316.00$390,207.00$31,869.00
2022-12-31$6,171.00-$713,606.00